Your browser doesn't support javascript.
loading
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.
Amiri, Mohammad Mehdi; Golsaz-Shirazi, Forough; Soltantoyeh, Tahereh; Hosseini-Ghatar, Reza; Bahadori, Tannaz; Khoshnoodi, Jalal; Navabi, Shadi Sadat; Farid, Samira; Karimi-Jafari, Mohammad Hossein; Jeddi-Tehrani, Mahmood; Shokri, Fazel.
Afiliación
  • Amiri MM; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Golsaz-Shirazi F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Soltantoyeh T; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Hosseini-Ghatar R; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Bahadori T; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Khoshnoodi J; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Navabi SS; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Farid S; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Karimi-Jafari MH; Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
  • Jeddi-Tehrani M; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. fshokri@tums.ac.ir.
Invest New Drugs ; 36(2): 171-186, 2018 04.
Article en En | MEDLINE | ID: mdl-28983766
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Invest New Drugs Año: 2018 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Invest New Drugs Año: 2018 Tipo del documento: Article País de afiliación: Irán